![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Celltrion’s DiaTrust COVID-19 Ag Home Test Earns EUA
Celltrion’s DiaTrust COVID-19 Ag Home Test Earns EUA
The FDA has issued an Emergency Use Authorization for a COVID-19 test from Celltrion USA, a subsidiary of South Korea-based Healthcare Celltrion.
The over-the-counter DiaTrust COVID-19 Ag Home Test is an immunoassay that detects the spike proteins on the SARS-CoV-2 coronavirus that causes COVID-19 infections.
Samples for the test are either self-collected, or collected by an assisting adult, on a direct nasal swab from people age 14 and up with symptoms of COVID-19 within seven days of the onset of symptoms.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct